Evidence map›Paper›PMID 38077122›Full record

ArticleiScience2023

Gene-metabolite annotation with shortest reactional distance enhances metabolite genome-wide association studies results.

Cantin Baron, Sarah Cherkaoui, Sandra Therrien-Laperriere, Yann Ilboudo, Raphaël Poujol, Pamela Mehanna, Melanie E Garrett, Marilyn J Telen, Allison E Ashley-Koch, Pablo Bartolucci and 5 more

Abstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Vitiligo Information Resource database v3.NPJ systems biology and applications · 2026
    Article
  2. Review
  3. Application of GWAS and mGWAS in Livestock and Poultry Breeding.Animals : an open access journal from MDPI · 2024
    Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Cantin BaronDépartement de Biochimie et de Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
Sarah CherkaouiMontreal Heart Institute, Montréal, QC, Canada.
Sandra Therrien-LaperriereMontreal Heart Institute, Montréal, QC, Canada.
Yann IlboudoDépartement de Biochimie et de Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
Raphaël PoujolMontreal Heart Institute, Montréal, QC, Canada.
Pamela MehannaMontreal Heart Institute, Montréal, QC, Canada.
Melanie E GarrettDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA.
Marilyn J TelenDivision of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Allison E Ashley-KochDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA.
Pablo BartolucciUniversité Paris Est Créteil, Hôpitaux Universitaires Henri Mondor, APHP, Sickle cell referral center - UMGGR, Créteil, France.
John D RiouxDépartement de Biochimie et de Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
Guillaume LettreMontreal Heart Institute, Montréal, QC, Canada.
Christine Des RosiersDépartement de Biochimie et de Médecine Moléculaire, Université de Montréal, Montréal, QC, Canada.
Matthieu RuizMontreal Heart Institute, Montréal, QC, Canada.
Julie G HussinMontreal Heart Institute, Montréal, QC, Canada.

Funding

Pulmonary Hypertension in SCDR01HL079915 · NHLBI · DUKE UNIVERSITY · PI TELEN, MARILYN J · 2005 to 2008
$6.7M
GENETIC MODIFIERS OF SEVERITY IN SICKLE CELL ANEMIAR01HL068922 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI PLATT, ORAH S · 2001 to 2005
$3.6M
Outcome Modifying Genes in Sickle Cell DiseaseR01HL068959 · NHLBI · DUKE UNIVERSITY · PI TELEN, MARILYN J · 2001 to 2005
$3.6M
Transcriptomic, therapeutic and genetic investigations of sickle cell nephropathyR01DK110104 · NIDDK · DUKE UNIVERSITY · PI ASHLEY-KOCH, ALLISON E, DAVIS, ERICA ELLEN · 2016 to 2018
$716k
Identifying novel clinical, genetic and proteomic risk factors for sickle cell nephropathy.R21DK124836 · NIDDK · DUKE UNIVERSITY · PI ASHLEY-KOCH, ALLISON E · 2021 to 2022
$443k
NHLBI NIH HHS R01 HL068922NHLBI NIH HHS R01 HL068959NHLBI NIH HHS R01 HL079915NIDDK NIH HHS R01 DK110104NIDDK NIH HHS R21 DK124836
6 · The paper itself

Abstract

Metabolite genome-wide association studies (mGWAS) have advanced our understanding of the genetic control of metabolite levels. However, interpreting these associations remains challenging due to a lack of tools to annotate gene-metabolite pairs beyond the use of conservative statistical significance threshold. Here, we introduce the shortest reactional distance (SRD) metric, drawing from the comprehensive KEGG database, to enhance the biological interpretation of mGWAS results. We applied this approach to three independent mGWAS, including a case study on sickle cell disease patients. Our analysis reveals an enrichment of small SRD values in reported mGWAS pairs, with SRD values significantly correlating with mGWAS p values, even beyond the standard conservative thresholds. We demonstrate the utility of SRD annotation in identifying potential false negatives and inaccuracies within current metabolic pathway databases. Our findings highlight the SRD metric as an objective, quantitative and easy-to-compute annotation for gene-metabolite pairs, suitable to integrate statistical evidence to biological networks.

Indexed as

Association analysisComputational bioinformaticsQuantitative genetics

Identifiers

PMID38077122
PMCPMC10709128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.